Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study.

Autor: Cutler C; Division of Transplantation and Cellular Therapy, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Lee SJ; Fred Hutchinson Cancer Research Center, Seattle, WA., Arai S; Stanford University Medical Center, Stanford, CA., Rotta M; Colorado Blood Cancer Institute, Denver, CO., Zoghi B; Texas Transplant Institute, Methodist Hospital, San Antonio, TX., Lazaryan A; Moffitt Cancer Center, Tampa, FL., Ramakrishnan A; St David's South Austin Medical Center, Austin, TX., DeFilipp Z; Massachusetts General Hospital, Boston, MA., Salhotra A; City of Hope Medical Center, Duarte, CA., Chai-Ho W; University of California, Los Angeles Medical Center, Los Angeles, CA., Mehta R; MD Anderson Cancer Center, Houston, TX., Wang T; University of Miami, Miami, FL., Arora M; University of Minnesota Masonic Cancer Center, Minneapolis, MN., Pusic I; Washington University School of Medicine, Saint Louis, MO., Saad A; The Ohio State University Wexner Medical Center, Columbus, OH., Shah NN; Froedtert Hospital and the Medical College of Wisconsin, Milwaukee, WI., Abhyankar S; The University of Kansas Cancer Center, Fairway, KS., Bachier C; Sarah Cannon Research Institute, Nashville, TN., Galvin J; University of Illinois at Chicago, Chicago, IL., Im A; University of Pittsburgh Medical Center-Hillman Cancer Center, Pittsburgh, PA., Langston A; Winship Cancer Institute of Emory University, Atlanta, GA., Liesveld J; University of Rochester, Rochester, NY., Juckett M; University of Wisconsin Carbone Cancer Center, Madison, WI., Logan A; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Schachter L; Oregon Health and Science University, Portland, OR., Alavi A; Barbara Ann Karmanos Cancer Institute, Detroit, MI., Howard D; Baptist Medical Center, Wake Forest University School of Medicine, Winston-Salem, NC., Waksal HW; Kadmon Corporation, New York, NY., Ryan J; Kadmon Corporation, New York, NY., Eiznhamer D; Kadmon Corporation, New York, NY., Aggarwal SK; Kadmon Corporation, New York, NY., Ieyoub J; Kadmon Corporation, New York, NY., Schueller O; Kadmon Corporation, New York, NY., Green L; Kadmon Corporation, New York, NY., Yang Z; Kadmon Corporation, New York, NY., Krenz H; Kadmon Corporation, New York, NY., Jagasia M; Vanderbilt-Ingram Cancer Center, Nashville, TN., Blazar BR; University of Minnesota, Minneapolis, MN; and., Pavletic S; Center for Cancer Research, National Cancer Institute, Bethesda, MD.

Publikováno v: Blood [Blood] 2021 Dec 02; Vol. 138 (22), pp. 2278-2289.